The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 3099 -3108
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, C.
Right arrow Articles by Maus, U. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, C.
Right arrow Articles by Maus, U. A.

FMS-Like Tyrosine Kinase 3 Ligand Aggravates the Lung Inflammatory Response to Streptococcus pneumoniae Infection in Mice: Role of Dendritic Cells1

Christine Winter*, Katharina Taut*, Florian Länger{dagger}, Matthias Mack{ddagger}, David E. Briles§, James C. Paton, Regina Maus*, Mrigank Srivastava*, Tobias Welte* and Ulrich A. Maus2,*

* Department of Pulmonary Medicine, Laboratory for Experimental Lung Research, and {dagger} Department of Pathology, Hannover School of Medicine, Hannover, Germany; {ddagger} Department of Internal Medicine, University of Regensburg, Regensburg, Germany; § Department of Microbiology, University of Alabama, Birmingham, AL 35294; and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia

Pretreatment of mice with the hemopoietic growth factor, FMS-like tyrosine kinase 3 ligand (Flt3L), has been shown to increase monocyte-derived myeloid dendritic cells (DC) in lung parenchymal tissue, with possible implications for protective immunity to lung bacterial infections. However, whether Flt3L treatment improves lung innate immunity of mice to challenge with Streptococcus pneumoniae has not been investigated previously. Mice pretreated with Flt3L exhibited a peripheral monocytosis and a strongly expanded lung myeloid DC pool, but responded with a similar proinflammatory cytokine release (TNF-{alpha}, IL-6, keratinocyte derived cytokine, MIP-2, CCL2) and neutrophilic alveolitis upon infection with S. pneumoniae as did control mice with a normal lung DC pool. Unexpectedly, however, Flt3L-pretreated mice, but not control mice, infected with S. pneumoniae developed vasculitis and increased lung permeability by days 2–3 postinfection, and florid pneumonia accompanied by sustained increased bacterial loads by days 3–4 postinfection. This was associated with an overall increased mortality of ~35% by day 4 after pneumococcal challenge. Application of anti-CCR2 Ab MC21 to block inflammatory monocyte-dependent lung mononuclear phagocyte mobilization significantly reduced the lung leakage, but not vasculitis in Flt3L-pretreated mice infected with S. pneumoniae, without affecting the intra-alveolar cytokine liberation or the concomitantly developing neutrophilic alveolitis. Together, the data demonstrate that previous Flt3L-induced lung DC accumulation is not protective in lung innate immunity to challenge with S. pneumoniae, and support the concept that CCR2-dependent mononuclear phagocyte as opposed to neutrophil recruitment contributes to increased lung leakage in Flt3L-pretreated mice challenged with S. pneumoniae.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study has been supported by the German Research Foundation, Deutsche Forschungsgemeinschaft Grant SFB 587 (to U.A.M. and T.W.).

2 Address correspondence and reprint requests to Dr. Ulrich A. Maus, Department of Pulmonary Medicine, Laboratory for Experimental Lung Research, Hannover School of Medicine, Hannover 30625, Germany. E-mail address: Maus.Ulrich{at}mh-hannover.de

3 Abbreviations used in this paper: Flt3L, FMS-like tyrosine kinase 3 ligand; BAL, bronchoalveolar lavage; DC, dendritic cell; FSC, forward light scatter; KC, keratinocyte derived cytokine; SSC, side light scatter.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Z. Shao, T. O. Makinde, H. S. McGee, X. Wang, and D. K. Agrawal
Fms-Like Tyrosine Kinase 3 Ligand Regulates Migratory Pattern and Antigen Uptake of Lung Dendritic Cell Subsets in a Murine Model of Allergic Airway Inflammation
J. Immunol., December 1, 2009; 183(11): 7531 - 7538.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. J. Osterholzer, J. E. Milam, G.-H. Chen, G. B. Toews, G. B. Huffnagle, and M. A. Olszewski
Role of Dendritic Cells and Alveolar Macrophages in Regulating Early Host Defense against Pulmonary Infection with Cryptococcus neoformans
Infect. Immun., September 1, 2009; 77(9): 3749 - 3758.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Winter, W. Herbold, R. Maus, F. Langer, D. E. Briles, J. C. Paton, T. Welte, and U. A. Maus
Important Role for CC Chemokine Ligand 2-Dependent Lung Mononuclear Phagocyte Recruitment to Inhibit Sepsis in Mice Infected with Streptococcus pneumoniae
J. Immunol., April 15, 2009; 182(8): 4931 - 4937.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Pene, B. Zuber, E. Courtine, C. Rousseau, F. Ouaaz, J. Toubiana, A. Tazi, J.-P. Mira, and J.-D. Chiche
Dendritic Cells Modulate Lung Response to Pseudomonas aeruginosa in a Murine Model of Sepsis-Induced Immune Dysfunction
J. Immunol., December 15, 2008; 181(12): 8513 - 8520.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Osterholzer, J. L. Curtis, T. Polak, T. Ames, G.-H. Chen, R. McDonald, G. B. Huffnagle, and G. B. Toews
CCR2 Mediates Conventional Dendritic Cell Recruitment and the Formation of Bronchovascular Mononuclear Cell Infiltrates in the Lungs of Mice Infected with Cryptococcus neoformans
J. Immunol., July 1, 2008; 181(1): 610 - 620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.